These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32141322)

  • 1. Local and Lymph Node Relapse of Nasopharyngeal Carcinoma: A Single-Center Experience.
    Toumi N; Ennouri S; Charfeddine I; Daoud J; Khanfir A
    Ear Nose Throat J; 2021 Sep; 100(5_suppl):795S-800S. PubMed ID: 32141322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
    Ng WT; Ngan RKC; Kwong DLW; Tung SY; Yuen KT; Kam MKM; Sze HCK; Yiu HHY; Chan LLK; Lung ML; Lee AWM
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):630-638. PubMed ID: 29413277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study.
    Zhao C; Miao JJ; Hua YJ; Wang L; Han F; Lu LX; Xiao WW; Wu HJ; Zhu MY; Huang SM; Lin CG; Deng XW; Xie CH
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):836-844. PubMed ID: 30954521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience.
    Majidova N; Sarı M; Kahvecioglu FA; Ozcan E; Akdag MO; Dogan A; Yıldırım S; Sonusen SD; Yunusov E; Yasar A; Celebi A; Sever N; Kocaaslan E; Erel P; Agyol Y; Guren AK; Arıkan R; Isık S; Balvan O; Geredelı C; Uygun K; Hacibekiroglu I; Kostek O; Bayoglu IV
    Oncol Res Treat; 2024; 47(7-8):360-367. PubMed ID: 38565096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
    Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X
    Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential induction chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: the three-year report of a phase II, single center, randomized, non-inferiority trial.
    Yang Z; Cai Z; Cai Q; Hong Y; Zhang C; Huang K; Lin Z; Li M
    Cancer Med; 2021 Jun; 10(12):3886-3895. PubMed ID: 33955190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma.
    Liao K; Tao HY; Zhan ZJ; Qiu WZ; Zheng RH
    Oncol Res Treat; 2021; 44(11):602-612. PubMed ID: 34601467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiotherapy by simultaneously integrated boost volumetric-modulated arc therapy for nasopharyngeal carcinoma-toxicity/quality of life and survival.
    Fang FM; Huang TL; Lin YH; Chien CY; Chuang HC; Luo SD; Lin HC; Lin YT; Li SH; Liao KC; Tsai WL
    Head Neck; 2019 May; 41(5):1282-1289. PubMed ID: 30548091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.
    Zong JF; Liang QD; Lu QJ; Liu YH; Xu HC; Chen BJ; Guo QJ; Xu Y; Hu CR; Pan JJ; Lin SJ
    BMC Cancer; 2021 Nov; 21(1):1274. PubMed ID: 34823489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
    Chua DT; Wei WI; Sham JS; Cheng AC; Au G
    Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience.
    Jouin A; Helfre S; Bolle S; Claude L; Laprie A; Bogart E; Vigneron C; Potet H; Ducassou A; Claren A; Riet FG; Castex MP; Faure-Conter C; Fresneau B; Defachelles AS; Orbach D
    Strahlenther Onkol; 2019 Jun; 195(6):504-516. PubMed ID: 30963203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine and Cisplatin followed by chemo-radiation for advanced nasopharyngeal carcinoma.
    Jamshed A; Hussain R; Iqbal H
    Asian Pac J Cancer Prev; 2014; 15(2):899-904. PubMed ID: 24568516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases.
    Lin C; Sun XS; Liu SL; Li XY; Lu N; Li XL; Tang LQ; Guo L
    Cancer Res Treat; 2020 Jul; 52(3):855-866. PubMed ID: 32164051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
    Liu W; Yu B; Luo Y; Li J; Yuan X; Wu S; Liang B; Lv Z; Li Y; Peng X; Lu J; Peng X; Liu X
    BMC Cancer; 2021 May; 21(1):639. PubMed ID: 34051750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term complications and prognostic factors in locally advanced nasopharyngeal carcinoma treated with docetaxel, cisplatin, 5-fluorouracil induction chemotherapy followed by concurrent chemoradiotherapy: A retrospective cohort study.
    Shim HJ; Kim HJ; Hwang JE; Bae WK; Chung IJ; Lee DH; Mi YT; Lee JK; Lim SC; Chung JW; Cho SH
    Medicine (Baltimore); 2020 Dec; 99(49):e23173. PubMed ID: 33285692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric modulated arctherapy for locally advanced nasopharyngeal carcinoma: Clinical efficacy and late toxicity.
    Hommadi M; N'da G; Bertrand C; Randriamaroson N; Benlemlih M; Mosse WBA; El Mejjaoui S; Kebdani T; El Kacemi H; Benjaafar N
    Cancer Radiother; 2022 May; 26(3):433-439. PubMed ID: 34366239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locally advanced nasopharyngeal carcinoma in adolescents treated with tomotherapy: Experience at King Faisal Specialist Hospital and Research Centre.
    Aldakheel A; Aldehaim M; Alwhaid MS; Alhabib R; Anwar MS; Alzayed B; Shehzad K; Ghebeh H; Al-Rajhi N
    Ann Saudi Med; 2024; 44(3):153-160. PubMed ID: 38853474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis.
    Wang BC; Xiao BY; Lin GH; Wang C; Liu Q
    BMC Cancer; 2020 May; 20(1):393. PubMed ID: 32375701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma.
    Uezono H; Indelicato DJ; Rotondo RL; Sandler ES; Katzenstein HM; Dagan R; Mendenhall WM; Mailhot Vega R; Brennan BM; Bradley JA
    Pediatr Blood Cancer; 2019 Dec; 66(12):e27990. PubMed ID: 31524334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
    Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.